• 1.

    Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97106.

  • 2.

    Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, 2007. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 7987.

  • 3.

    2006. Malaria Vaccine Technology Roadmap. Available at: http://www.malariavaccine.org/files/Malaria_Vaccine_TRM_Final.pdf.

  • 4.

    Herrera S, Corradin G, Arévalo-Herrera M, 2007. An update on the search for a Plasmodium vivax vaccine. Trends Parasitol 23: 122128.

  • 5.

    Guerra CA, Snow RW, Hay SI, 2006. Mapping the global extent of malaria in 2005. Trends Parasitol 22: 353358.

  • 6.

    Yeom JS, Kim TS, Oh S, Sim JB, Barn JS, Kim HJ, Kim YA, Ahn SY, Shin MY, Yoo JA, Park JW, 2007. Plasmodium vivax malaria in the Republic of Korea during 2004–2005: changing patterns of infection. Am J Trop Med Hyg 76: 865868.

    • Search Google Scholar
    • Export Citation
  • 7.

    Faulde MK, Hoffmann R, Fazilat KM, Hoerauf A, 2007. Malaria reemergence in northern Afghanistan. Emerg Infect Dis 13: 14021404.

  • 8.

    Aramburu Guarda J, Ramal Asayag C, Witzig R, 1999. Malaria reemergence in the Peruvian Amazon region. Emerg Infect Dis 5: 209215.

  • 9.

    PAHO, 2003. Informe de la situación de los programas de malaria en las Américas. Available at: http://www.paho.org/Spanish/AD/DPC/CD/programas-nacionales.pdf.

    • Search Google Scholar
    • Export Citation
  • 10.

    Joshi H, Prajapati SK, Verma A, Kang'a S, Carlton JM, 2008. Plasmodium vivax in India. Trends Parasitol 24: 228235.

  • 11.

    Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R, 2003. The paroxysm of Plasmodium vivax malaria. Trends Parasitol 19: 188193.

  • 12.

    Ozen M, Gungor S, Atambay M, Daldal N, 2006. Cerebral malaria owing to Plasmodium vivax: case report. Ann Trop Paediatr 26: 141144.

  • 13.

    Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A, 2005. Plasmodium vivax malaria. Emerg Infect Dis 11: 132134.

  • 14.

    Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN, 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: e128.

    • Search Google Scholar
    • Export Citation
  • 15.

    Price L, Planche T, Rayner C, Krishna S, 2007. Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature. Trans R Soc Trop Med Hyg 101: 655659.

    • Search Google Scholar
    • Export Citation
  • 16.

    Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN, 2008. Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis 46: 13741381.

    • Search Google Scholar
    • Export Citation
  • 17.

    Valderrama-Aguirre A, Quintero G, Gomez A, Castellanos A, Perez Y, Mendez F, Arévalo-Herrera M, Herrera S, 2005. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 Pv200L: a potential malaria vaccine subunit. Am J Trop Med Hyg 73: 1624.

    • Search Google Scholar
    • Export Citation
  • 18.

    Herrera SB, Perlaza BL, Fernández OL, Victoria L, Lenis AM, Soto L, Hurtado H, Acuña LM, Vélez JD, Palacios R, Chen-Mok M, Corradin G, Arévalo-Herrera M, 2005. Safety and elicitation of humoral and cellular responses in Colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine. Am J Trop Med Hyg 73 (Suppl): 39.

    • Search Google Scholar
    • Export Citation
 
 
 

 

 
 
 

 

 

 

 

 

 

Plasmodium vivax Vaccine Research: Insights from Colombian Studies

View More View Less
  • PATH-Malaria Vaccine Initiative, Bethesda, Maryland; Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland; Nuffield Department of Clinical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

Author Notes

*Address correspondence to Falgunee K. Parekh, CAMRIS International, 6931 Arlington Road, Suite 575, Bethesda, MD 20814. E-mail: falgunee_parekh@yahoo.com

Authors' addresses: Falgunee Parekh, CAMRIS International, 6931 Arlington Road, Suite 575, Bethesda, MD 20814, E-mail: falgunee_parekh@yahoo.com. Vasee S. Moorthy, Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland, E-mail: moorthyv@who.int.

Save